Nisa Investment Advisors
ADMA icon

Nisa Investment Advisors’s ADMA Biologics ADMA Stock Holding History

Nisa Investment Advisors’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$43.2K Buy
5,163
+2,231
+76% +$20.3K ﹤0.01% 1908
2026
Q1 		$26.4K Sell
2,932
-1,548
-35% -$24.4K ﹤0.01% 1911
2025
Q4 		$81.7K Sell
4,480
-3,454
-44% -$58.2K ﹤0.01% 1495
2025
Q3 		$116K Buy
7,934
+2,665
+51% +$45.7K ﹤0.01% 1388
2025
Q2 		$95.9K Sell
5,269
-297
-5% -$6.06K ﹤0.01% 1408
2025
Q1 		$110K Sell
5,566
-1,812
-25% -$31.3K ﹤0.01% 1374
2024
Q4 		$127K Buy
7,378
+4,224
+134% +$79.5K ﹤0.01% 1410
2024
Q3 		$63K Sell
3,154
-1,453
-32% -$22.6K ﹤0.01% 1582
2024
Q2 		$51.5K Sell
4,607
-199,828
-98% -$1.68M ﹤0.01% 1659
2024
Q1 		$1.35M Buy
204,435
+200,209
+4,738% +$1.09M 0.01% 787
2023
Q4 		$19.1K Hold
4,226
– – ﹤0.01% 1896
2023
Q3 		$15.1K Hold
4,226
– – ﹤0.01% 2087
2023
Q2 		$15.6K Sell
4,226
-890
-17% -$3.3K ﹤0.01% 2167
2023
Q1 		$17K Hold
5,116
– – ﹤0.01% 2050
2022
Q4 		$20K Hold
5,116
– – ﹤0.01% 2052
2022
Q3 		$14K Buy
5,116
+206
+4% +$494 ﹤0.01% 2123
2022
Q2 		$10K Buy
+4,910
New +$9.66K ﹤0.01% 2178

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $20.2B AUM 29.18% 1-Year Est. Return
MCM
Marathon Capital Management Hunt Valley, Maryland $494M AUM 42.6% 1-Year Est. Return

Nisa Investment Advisors's ADMA Position: Q2 2026 in Review

Nisa Investment Advisors increased its ADMA Biologics (ADMA) stake by 76% in Q2 2026, buying an estimated $20.3K and bringing the position to 5,163 shares worth $43.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1908.

Nisa Investment Advisors first reported a position in ADMA in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.35M in Q1 2024. 139 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Nisa Investment Advisors held 5,163 shares of ADMA Biologics worth $43.2K as of Q2 2026.
  • Nisa Investment Advisors bought 2,231 ADMA Biologics shares in Q2 2026, an estimated $20.3K.
  • ADMA Biologics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1908 holding.
  • Nisa Investment Advisors first reported a position in ADMA Biologics in Q2 2022 and has held it in 17 quarters since.
  • Nisa Investment Advisors's ADMA Biologics position peaked at $1.35M in Q1 2024.
  • 139 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.